COMPASS THERAPEUTICS INC (CMPX) Stock Earnings & Estimates
USA - NASDAQ:CMPX - US20454B1044 - Common Stock
3.74 USD
+0.25 (+7.16%)
3.7994 USD
+0.06 (+1.59%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 850K | -100.00% | 8.596M | 72.848M 747.46% | 204.65M 180.93% | 363.3M 77.52% | 650.19M 78.97% | 1.403B 115.78% | 2.189B 56.02% | |||
| EBITDA YoY % growth | -40.88M 49.72% | -49.664M -21.49% | -56.036M -12.83% | -85.792M -53.10% | -105.881M -23.42% | -91.509M 13.57% | -41.514M 54.63% | 28.733M 169.21% | 124.36M 332.81% | 168.03M 35.12% | 211.51M 25.88% | |
| EBIT YoY % growth | -41.66M 49.12% | -50.363M -20.89% | -56.625M -12.43% | -82.715M -46.08% | -98.045M -18.53% | -85.149M 13.15% | 21.433M 125.17% | 138.92M 548.16% | 375.27M 170.13% | 1.07B 185.13% | 1.769B 65.33% | |
| Operating Margin | N/A | N/A | -6,661.76% | N/A | -1,140.59% | -116.89% | 10.47% | 38.24% | 57.72% | 76.27% | 80.81% | |
| EPS YoY % growth | -0.37 69.70% | -0.34 8.11% | -0.37 -8.82% | -0.56 -52.09% | -0.58 -2.76% | -0.56 2.79% | -0.02 96.97% | 0.57 3,465.27% | 1.93 237.37% | 4.67 141.56% | 6.78 45.14% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -82.71% | -0.15 -33.53% | -0.15 -23.89% | -0.14 -3.27% | -0.11 26.03% | -0.09 37.22% | -0.12 17.67% | -0.10 29.45% | -0.08 24.53% | -0.04 55.75% |
| Revenue Q2Q % growth | 3.409M | 17.057M | 5.1M | 10.2M | 15.3M 348.81% | 25.775M 51.11% | ||||
| EBITDA Q2Q % growth | -22.69M -92.45% | -23.429M -46.57% | -26.5M -52.38% | -27.377M -34.63% | -28.356M -24.97% | -28.958M -23.60% | -29.539M -11.47% | -27.601M -0.82% | -22.399M 21.01% | -14.637M 49.45% |
| EBIT Q2Q % growth | -21.399M -74.84% | -21.242M -28.17% | -23.525M -41.63% | -24.089M -14.35% | -20.744M 3.06% | -18.932M 10.88% | -22.817M 3.01% | -19.186M 20.35% | -15.555M 25.01% | -7.64M 59.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.14 -40.00% | -0.13 | -0.01 | -10.69% |
| Q1 2025 Q2Q % growth | -0.12 -50.00% | -0.11 | -0.01 | -5.99% |
| Q4 2024 Q2Q % growth | -0.11 | -0.10 | -0.01 | -9.93% |
| Q3 2024 Q2Q % growth | -0.08 | -0.12 | 0.04 | 30.79% |
| Q2 2024 Q2Q % growth | -0.10 -11.11% | -0.10 | 0.00 | -3.20% |
| Q1 2024 Q2Q % growth | -0.08 -33.33% | -0.12 | 0.04 | 30.51% |
| Q4 2023 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -14.56% |
| Q3 2023 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 26.80% |
| Q2 2023 Q2Q % growth | -0.09 -12.50% | -0.08 | -0.01 | -8.36% |
| Q1 2023 Q2Q % growth | -0.06 14.29% | -0.11 | 0.05 | 45.82% |
| Q4 2022 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 12.85% |
| Q3 2022 Q2Q % growth | -0.12 -20.00% | -0.11 | -0.01 | -10.29% |
| Q2 2022 Q2Q % growth | -0.08 | -0.09 | 0.01 | 6.95% |
| Q1 2022 Q2Q % growth | -0.07 | -0.11 | 0.04 | 37.61% |
| Q4 2021 Q2Q % growth | -0.21 | -0.07 | -0.14 | -182.57% |
| Q3 2021 Q2Q % growth | -0.10 | -0.13 | 0.03 | 21.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -11.27% | -3.37% | -10.24% |
| Revenue | N/A | N/A | N/A | N/A |